Segment disclosures

Company overview

Pathfinder Cell Therapy, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

10 dimension combinations 58 retained observations 10 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

BR

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=country:BR
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-318 RestatedUSD20150331Open filing evidence
2013-07-01 – 2013-09-308000 USD20131114Open filing evidence
2013-01-01 – 2013-09-308000 USD20131114Open filing evidence
2012-01-01 – 2012-12-3117000 USD20140527Open filing evidence

CO

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=country:CO
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-12-3115000 USD20140527Open filing evidence
2012-01-01 – 2012-09-3014000 USD20131114Open filing evidence
2012-04-01 – 2012-06-3014000 RestatedUSD20130814Open filing evidence
2012-01-01 – 2012-06-3014000 RestatedUSD20130814Open filing evidence

HK

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=country:HK
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-316 RestatedUSD20150331Open filing evidence
2013-01-01 – 2013-09-306000 USD20131114Open filing evidence
2013-01-02 – 2013-06-306000 USD20130814Open filing evidence
2013-01-01 – 2013-03-316000 USD20140515Open filing evidence
2012-01-01 – 2012-12-3137000 USD20140527Open filing evidence
2012-07-01 – 2012-09-3010000 USD20131114Open filing evidence
2012-01-01 – 2012-09-3028000 USD20131114Open filing evidence
2012-04-01 – 2012-06-3011000 RestatedUSD20130814Open filing evidence
2012-01-01 – 2012-06-3018000 RestatedUSD20130814Open filing evidence
2012-01-01 – 2012-03-317000 USD20130515Open filing evidence
2011-01-01 – 2011-12-3154000 USD20140331Open filing evidence

IT

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=country:IT
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-12-312000 USD20140527Open filing evidence
2012-07-01 – 2012-09-302000 USD20131114Open filing evidence
2012-01-01 – 2012-09-302000 USD20131114Open filing evidence
2011-01-01 – 2011-12-315000 USD20140331Open filing evidence
2011-07-01 – 2011-09-305000 USD20121114Open filing evidence
2011-01-01 – 2011-09-305000 USD20121114Open filing evidence

PK

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=country:PK
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-09-303000 USD20131114Open filing evidence
2013-01-02 – 2013-06-303000 USD20130814Open filing evidence
2013-01-01 – 2013-03-313000 USD20140515Open filing evidence

RU

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=country:RU
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-3127 RestatedUSD20150331Open filing evidence
2013-01-01 – 2013-09-3027000 USD20131114Open filing evidence
2013-04-01 – 2013-06-3018000 USD20130814Open filing evidence
2013-01-02 – 2013-06-3027000 USD20130814Open filing evidence
2013-01-01 – 2013-03-319000 USD20140515Open filing evidence
2012-01-01 – 2012-12-3115000 USD20140527Open filing evidence
2012-07-01 – 2012-09-303000 USD20131114Open filing evidence
2012-01-01 – 2012-09-3016000 USD20131114Open filing evidence
2012-04-01 – 2012-06-303000 RestatedUSD20130814Open filing evidence
2012-01-01 – 2012-06-3013000 RestatedUSD20130814Open filing evidence
2012-01-01 – 2012-03-3110000 USD20130515Open filing evidence

US

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=country:US
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-12-3113000 USD20140527Open filing evidence
2012-01-01 – 2012-09-3013000 USD20131114Open filing evidence
2012-04-01 – 2012-06-301000 RestatedUSD20130814Open filing evidence
2012-01-01 – 2012-06-3013000 RestatedUSD20130814Open filing evidence
2012-01-01 – 2012-03-3112000 USD20130515Open filing evidence
2011-01-01 – 2011-12-317000 USD20140331Open filing evidence

MCZK

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=exch:MCZK
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-3110000 USD20140527Open filing evidence
2013-01-01 – 2013-09-3010000 USD20131114Open filing evidence
2013-01-02 – 2013-06-3010000 USD20130814Open filing evidence
2013-01-01 – 2013-03-3110000 USD20140515Open filing evidence
2012-01-01 – 2012-12-3115000 USD20140527Open filing evidence
2012-07-01 – 2012-09-305000 USD20131114Open filing evidence
2012-01-01 – 2012-09-3010000 USD20131114Open filing evidence
2012-01-01 – 2012-06-305000 RestatedUSD20130814Open filing evidence
2012-01-01 – 2012-03-315000 USD20130515Open filing evidence
2011-01-01 – 2011-12-315000 USD20140331Open filing evidence

Mczk

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pfnd:MczkMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-3110000 USD20150331Open filing evidence

Other Countries

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pfnd:OtherCountriesMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-313 RestatedUSD20150331Open filing evidence
2011-01-01 – 2011-12-312000 USD20140331Open filing evidence